The top 100 pharmaceutical retailing list was released, with the top five companies receiving more than $10 billion in 2019.

"Pharmaceutical Network Industry Dynamics" Recently, the China Pharmaceutical Business Association officially released the "2019 China's drug circulation industry retail top 100 enterprises list."
it is understood that the above list used data from the Ministry of Commerce drug circulation management system, in the industry directly reported enterprises to report data statistics, and then according to the domestic pharmaceutical retail enterprises in 2019 total sales ranking.
Among them, the top five are Guoda Pharmacy Co., Ltd., the people's big pharmacy chain Co., Ltd., DasinLin Pharmaceutical Group Co., Ltd., Yiyitang Pharmaceutical Group Co., Ltd., Yifeng Da Pharmacy Chain Co., Ltd.
note that as of December 31, 2019, all five companies had annual revenues of more than $10 billion, according to the major chain annual reports.
specifically, in fiscal 2019, the total operating income of the University pharmacies was 12.754 billion yuan, up 17.24% YoY; Year-on-year growth of 25.76 percent, Yifang achieved rapid growth in sales revenue of 10.479 billion yuan, up 14.20% from a year earlier, and Yifeng Pharmacy maintained the same growth in operating size and operating profit, achieving operating income of 10.276 billion yuan, up 48.66 percent year-on-year.
fact, from the above data can be seen, online pharmacy competition tends to saturate the background, listed pharmaceutical retail leading its market share is further enhanced.
, particularly retail head companies, are still expanding steadily.
the pharmaceutical industry believes that the era of pharmaceutical retail expansion may be coming.
based on two main analyses.
first and foremost prescription outflows have become a trend.
with the promotion of new medical reform policies such as medical insurance control fees, zero drug rates in public hospitals, drug ratio restrictions, and reform of medical insurance payment methods, the outflow of prescriptions from medical institutions has been indirectly promoted, and the flow of patients to retail pharmacies has been promoted.
followed by growing demand for big health.
With the aging of the population, as well as the upgrading of health awareness, the people's consumption capacity continues to improve, the demand for large health products and services from the treatment of diseases to treatment of diseases (including prevention, well-being and many other areas) extended, more diversified, personalized, forming a full life cycle of large health management needs, and further for the pharmaceutical retail market to bring room for development.
, with the pace of China's medical reform gradually accelerated, retail pharmacies are gradually moving towards standardization, specialization, competition is more market-oriented.
background, for the industry's leading enterprises, there will be interests in further consolidating the position and achieving considerable development.
the future, will also be more good brand drugstore chain leader growth.
.